Moazen B, Saeedi Moghaddam S, Silbernagl MA, Lotfizadeh M, Bosworth RJ, Alammehrjerdi Z, et al. Prevalence of drug injection, sexual activity, tattooing, and piercing among prison inmates. Epidemiol Rev. 2018;40(1):58–69.
Dolan K, Wirtz AL, Moazen B, Ndeffo-Mbah M, Galvani A, Kinner SA, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. The Lancet. 2016;388(10049):1089–102.
Golrokhi R, Farhoudi B, Taj L, Pahlaviani FG, Mazaheri-Tehrani E, Cossarizza A, et al. HIV prevalence and correlations in prisons in different regions of the world: a review article. Open AIDS J. 2018;12:81.
Akbari M, Akbari M, Naghibzadeh-Tahami A, Joulaei H, Nasiriyan M, Hesampour M, et al. Prevalence of HIV/AIDS among iranian prisoners: a review article. Addict health. 2016;8(3):195.
Valera P, Chang Y, Lian Z. HIV risk inside US prisons: a systematic review of risk reduction interventions conducted in US prisons. AIDS Care. 2017;29(8):943–52.
Mirzazadeh A, Shokoohi M, Navadeh S, Danesh A, Jain JP, Sedaghat A, et al. Underreporting in HIV-related high-risk behaviors: comparing the results of multiple data collection methods in a behavioral survey of prisoners in Iran. Prison J. 2018;98(2):213–28.
Adams J, Nowels C, Corsi K, Long J, Steiner JF, Binswanger IA. HIV risk after release from prison: a qualitative study of former inmates. J Acquir Immune Defic Syndr. 2011;57(5):429.
Nelwan EJ, Diana A, van Crevel R, Alam NN, Alisjahbana B, Pohan HT, et al. Indonesian prisons and HIV: part of the problem, part of the solution. Acta Med Indones. 2009;41(Suppl 1):52–6.
World Prison Brief [Internet]. Available from [https://www.prisonstudies.org/country/iran]. Accessed 10 Nov 2022.
Assari S, Yarmohamadivasel M, Moghani Lankarani M, Sehat M, Narenjiha H, Rafiey H, et al. Having multiple sexual partners among iranian intra-venous drug users. Front Psychiatry. 2014;5:125.
Ghasemzadeh I, Zare Shahri R, Namazi SA, Sadeghi P, Namazi SS, Ghasemzade A. Review of HIV risk factors in prison inmates in Iran. Life Sci J. 2014;11(4s):236–9.
Navadeh S, Mirzazadeh A, Gouya MM, Farnia M, Alasvand R, Haghdoost A-A. HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey, 2009. Sex Transm Infect. 2013;89(Suppl 3):iii33–6.
SeyedAlinaghi SA, Farhoudi B, Mohraz M, Pahlaviani FG, Hosseini M, Farnia M, et al. Prevalence and correlates of HIV infection among male prisoners in Tehran, Iran. Arch Iran Med. 2017;20(6):356–60.
Amin-Esmaeili M, Rahimi‐Movaghar A, Haghdoost Aa, Mohraz M. Evidence of HIV epidemics among non‐injecting drug users in I ran: a systematic review. Addiction. 2012;107(11):1929–38.
Haghdoost A-A, Mirzazadeh A, Shokoohi M, Sedaghat A, Gouya MM. HIV trend among iranian prisoners in 1990 s and 2000 s; analysis of aggregated data from HIV sentinel sero-surveys. Harm Reduct J. 2013;10(1):1–5.
Alam-Mehrjerdi Z, Abdollahi M, Higgs P, Dolan K. Drug use treatment and harm reduction programs in Iran: a unique model of health in the most populated Persian Gulf country. Asian J Psychiatry. 2015;16:78–83.
Nissaramanesh B, Trace M, Roberts M. The rise of harm reduction in the Islamic Republic of Iran. Beckley Foundation Drug Policy Programme, Briefing Paper. 2005;8.
Himmich H, Madani N. The state of harm reduction in the Middle East and North Africa: a focus on Iran and Morocco. Int J Drug Policy. 2016;31:184–9.
Roshanfekr P, Farnia M, Dejman M. The effectiveness of harm reduction programs in seven prisons of Iran. Iran J public health. 2013;42(12):1430.
Eshrati B, Asl RT, Dell CA, Afshar P, Millson PM, Kamali M, et al. Preventing HIV transmission among iranian prisoners: initial support for providing education on the benefits of harm reduction practices. Harm Reduct J. 2008;5(1):1–7.
HIV/AIDS JUNPo. Global AIDS response progress reporting. Egypt Geneva: UNAIDS; 2015.
Farhoudi B, SeyedAlinaghi S, Tabarsi P, Mohraz M, Golrokhy R, Farnia M, et al. Revision and implementation of “Clinical Guideline for tuberculosis and HIV in Prisons”, Great Tehran Prison, Iran. Infect Disord Drug Targets. 2018;18(1):72–80.
Shokoohi M, Karamouzian M, Osooli M, Sharifi H, Fahimfar N, Haghdoost A, et al. Low HIV testing rate and its correlates among men who inject drugs in Iran. Int J Drug Policy. 2016;32:64–9.
Shokoohi M, Karamouzian M, Khajekazemi R, Osooli M, Sharifi H, Haghdoost AA, et al. Correlates of HIV testing among female sex workers in Iran: findings of a national bio-behavioural surveillance survey. PLoS ONE. 2016;11(1):e0147587.
Shokoohi M, Noori A, Karamouzian M, Sharifi H, Khajehkazemi R, Fahimfar N, et al. Remaining gap in HIV testing uptake among female sex workers in Iran. AIDS Behav. 2017;21(8):2401–11.
Saberi Zafarghandi MB, Eshrati S, Arezoomandan R, Farnia M, Mohammadi H, Vahed N, et al. Review, Documentation, Assessment of Treatment, and Harm Reduction Programs of Substance Use Disorder in iranian prisons. Iran J Psychiatry Clin Psychol. 2021;27(1):48–63.
Shahesmaeili A, Shokoohi M, Tavakoli F, Rabiee MH, Kamali K, Haghdoost AA, et al. Prevalence of Symptom-based sexually transmitted infections and related factors among incarcerated men in Iran, 2013. Med J Islamic Repub Iran (MJIRI). 2021;35(1):1269–74.
Perovic B. Defining youth in contemporary national legal and policy frameworks across Europe. Partnership between the European Commission and the Council of Europe in the field of youth. 2016.
Khezri M, Mirzazadeh A, McFarland W, Iranpour A, Shahesmaeili A, Zarei J, et al. Prevalence of substance use and associated risk factors among homeless youth in Iran: a cross-sectional study. Child Youth Serv Rev. 2020;116:105070.
Haghdoost AA, Mostafavi E, Mirzazadeh A, Navadeh S, Feizzadeh A, Fahimfar N, et al. Modelling of HIV/AIDS in Iran up to 2014. J AIDS HIV Res. 2011;3(12):231–9.
Tabana H, Doherty T, Swanevelder S, Lombard C, Jackson D, Zembe W, et al. Knowledge of HIV status prior to a community HIV counseling and testing intervention in a rural district of South Africa: results of a community based survey. BMC Infect Dis. 2012;12(1):1–8.
Jean K, Anglaret X, Moh R, Lert F, Dray-Spira R. Barriers to HIV testing in Côte d’Ivoire: the role of individual characteristics and testing modalities. PLoS ONE. 2012;7(7):e41353.
Anderson KG, Beutel AM, Maughan-Brown B. HIV risk perceptions and first sexual intercourse among youth in Cape Town, South Africa. Int Fam Plan Perspect. 2007;33(3):98–105. https://doi.org/10.1363/ifpp.33.098.07.
Burchell AN, Calzavara LM, Myers T, Schlossberg J, Millson M, Escobar M, et al. Voluntary HIV testing among inmates: sociodemographic, behavioral risk, and attitudinal correlates. JAIDS J Acquir Immune Defic Syndr. 2003;32(5):534–41.
Rosen DL, Schoenbach VJ, Wohl DA, White BL, Stewart PW, Golin CE. An evaluation of HIV testing among inmates in the North Carolina prison system. Am J Public Health. 2009;99(S2):452-S9.
Ohiri K, Claeson M, Rassaghi E, Nassirimanesh B, Afshar P, Power R. HIVAIDS prevention among injection drug users: learning from harm reduction in Iran. Iran: HIV Prevention Consultation. 2006, 17–20.
Grodensky CA, Rosen DL, Hino S, Golin CE, Wohl DA. Opt-out HIV testing of inmates in North Carolina prisons: factors associated with not wanting a test and not knowing they were tested. AIDS Behav. 2016;20(4):859–69.
Tulloch HE, Balfour L, Kowal J, Tasca GA, Angel JB, Garber G, et al. HIV knowledge among canadian-born and sub-saharan african-born patients living with HIV. J Immigr Minor Health. 2012;14(1):132–9.